Cargando…
Ifosfamide-induced encephalopathy: the EEG with frontal intermittent delta activity, and rapid resolution with methylene blue: A case report
BACKGROUND: Encephalopathy is an established side effect of the chemotherapeutic agent, ifosfamide, occurring in 10–30% of cases. The EEG commonly shows non-specific features of encephalopathy, and rarely shows frontal intermittent rhythmic delta activity (FIRDA). CASE PRESENTATION: This is a case r...
Autores principales: | Hamilton, Juliette E., Alexander, Michael, Kelleher, Fergal C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700704/ https://www.ncbi.nlm.nih.gov/pubmed/33292592 http://dx.doi.org/10.1186/s13569-020-00147-3 |
Ejemplares similares
-
Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature
por: Pelgrims, J, et al.
Publicado: (2000) -
Ifosfamide-Induced Metabolic Encephalopathy in 2 Patients With Cutaneous T-Cell Lymphoma Successfully Treated With Methylene Blue
por: Vakiti, Anusha, et al.
Publicado: (2018) -
Ifosfamide-Induced Encephalopathy Successfully Prevented by Methylene Blue: A Pediatric Case Report and Review of the Literature
por: Furui, Yu, et al.
Publicado: (2023) -
Serotonin Syndrome Complicating Treatment of Ifosfamide Neurotoxicity With Methylene Blue
por: Snyder, Matthew, et al.
Publicado: (2017) -
A novel case of prolonged Ifosfamide encephalopathy and long-term treatment with methylene blue: a case report and review of literature
por: Chain, Gabriel, et al.
Publicado: (2022)